• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD68 免疫组化在浆膜腔细胞学中对良性非间皮细胞群进行分类和细化“非典型”类别中的作用。

Role of CD68 immunohistochemistry in categorizing benign nonmesothelial cell population and refining "atypical" category in serous fluid cytology.

机构信息

Department of Pathology, MetroHealth Medical Center, Case Western Reserve University, Cleveland, Ohio, USA.

Department of Psychiatry, Case Western Reserve University, Cleveland, Ohio, USA.

出版信息

Diagn Cytopathol. 2020 Dec;48(12):1199-1204. doi: 10.1002/dc.24541. Epub 2020 Jul 9.

DOI:10.1002/dc.24541
PMID:32644272
Abstract

BACKGROUND

Body fluids are rich in histiocytes and may mimic atypical epithelial cells morphologically. Histiocytes can pose a significant challenge in serous fluid cytology as they tend to appear atypical due to prolonged accumulation in serous fluids in vivo and processing by liquid-based cytology in vitro. Not many studies have documented the utilization of histiocytic marker such as CD68 in serous fluid cytology, which can subsequently reduce the "atypical" diagnostic category.

METHODS

One thousand one hundred and twenty-nine cases of serous fluid cytology from 2016 to 2019 were reviewed and reclassified based on proposed classification of the international system for reporting serous fluid cytology. There were 133 cases with atypical diagnoses, out of which 51 cases had cellblocks. An immunohistochemistry (IHC) panel, including two mesothelial markers, two epithelial markers, and one histiocytic marker was applied to the atypical samples. Same IHC panel was utilized to evaluate 15 cases each from negative for malignancy (NFM), suspicious for malignancy (SFM), and malignant (MAL) categories for further comparison.

RESULTS

After reevaluation of the cytology material with IHC stains, 924 (82%), 133 (12%), 23 (2%), and 49 (4%) of the cases were reclassified as NFM, atypia of uncertain significance, SFM, and MAL, respectively. Twenty-five out of 51 atypical cases (49%) were downgraded to "benign" after reevaluation with CD68 IHC.

CONCLUSION

Histiocytes can mimic atypical epithelial cells in body fluids. Effective utilization of CD68 IHC will be beneficial in further refining the "atypical" diagnostic category in serous fluid cytology.

摘要

背景

体液中富含组织细胞,其形态学表现可能类似于非典型上皮细胞。由于组织细胞在体内的浆膜液中长时间蓄积,并在体外的液体基础细胞学处理过程中发生改变,因此在浆膜液细胞学检查中,它们往往表现出非典型性,这给诊断带来了很大的挑战。目前,在浆膜液细胞学检查中,利用组织细胞标志物(如 CD68)的研究并不多,而这可能会减少“非典型”的诊断类别。

方法

对 2016 年至 2019 年的 1129 例浆膜液细胞学检查病例进行了回顾性分析,并根据国际浆膜液细胞学报告系统提出的分类方法进行了重新分类。其中,有 133 例为不典型诊断病例,其中 51 例有细胞块。对这些不典型样本应用了免疫组织化学(IHC)检测,包括两种间皮标志物、两种上皮标志物和一种组织细胞标志物。同样的 IHC 检测也用于评估阴性恶性肿瘤(NFM)、可疑恶性肿瘤(SFM)和恶性肿瘤(MAL)组的各 15 例病例,以进行进一步比较。

结果

在使用 IHC 染色重新评估细胞学材料后,924 例(82%)、133 例(12%)、23 例(2%)和 49 例(4%)病例分别被重新分类为 NFM、意义不明的非典型性、SFM 和 MAL。在对 51 例不典型病例中的 25 例(49%)进行 CD68 IHC 重新评估后,其诊断降级为“良性”。

结论

组织细胞在体液中可能模拟非典型上皮细胞。有效的 CD68 IHC 利用将有助于进一步细化浆膜液细胞学检查中的“非典型”诊断类别。

相似文献

1
Role of CD68 immunohistochemistry in categorizing benign nonmesothelial cell population and refining "atypical" category in serous fluid cytology.CD68 免疫组化在浆膜腔细胞学中对良性非间皮细胞群进行分类和细化“非典型”类别中的作用。
Diagn Cytopathol. 2020 Dec;48(12):1199-1204. doi: 10.1002/dc.24541. Epub 2020 Jul 9.
2
Application of the newly published International System for Reporting Serous Fluid Cytopathology in atypical and suspicious diagnosis: a four-year retrospective analysis.新发布的国际浆膜腔液细胞病理学报告系统在非典型和可疑诊断中的应用:一项四年回顾性分析。
J Am Soc Cytopathol. 2024 Jul-Aug;13(4):303-308. doi: 10.1016/j.jasc.2024.03.001. Epub 2024 Mar 19.
3
Application of the International System for Reporting Serous Fluid Cytopathology (ISRSFC) on Reporting Pericardial Effusion Cytology.国际浆膜液细胞病理学报告系统(ISRSFC)在心包积液细胞学报告中的应用。
Acta Cytol. 2020;64(5):477-485. doi: 10.1159/000507311. Epub 2020 May 18.
4
Application of international system for reporting serous fluid cytology (ISRSFC) in effusion samples-a prospective study in an oncology setting.国际浆膜腔液细胞学报告系统(ISRSFC)在积液标本中的应用——一项肿瘤学环境中的前瞻性研究。
J Am Soc Cytopathol. 2023 Sep-Oct;12(5):351-361. doi: 10.1016/j.jasc.2023.04.005. Epub 2023 May 3.
5
Risk Stratification of Pleural Fluid Cytology Based on the International System for Reporting Serous Fluid Cytology in a Tertiary Care Centre.基于国际浆膜腔液细胞报告系统在三级医疗中心的胸腔液细胞学风险分层。
Acta Cytol. 2022;66(5):449-456. doi: 10.1159/000524144. Epub 2022 Apr 12.
6
A Retrospective Analysis of the Application of the Newly Proposed International System for Reporting Serous Fluid Cytopathology on Serous Effusion Specimens: An Institutional Experience.回顾性分析新提出的国际浆膜腔液细胞病理学报告系统在浆膜腔积液标本中的应用:机构经验。
Acta Cytol. 2023;67(1):70-79. doi: 10.1159/000527398. Epub 2022 Dec 7.
7
The utilization and utility of immunostains in body fluid cytology.体液细胞学中免疫染色的应用和效用。
Cancer Cytopathol. 2020 Jun;128(6):384-391. doi: 10.1002/cncy.22256. Epub 2020 Mar 12.
8
The value of a tiered cytology diagnostic reporting system in assessing the risk of malignancy in indeterminate serous effusions.在评估不确定的浆膜液恶性肿瘤风险中,分层细胞学诊断报告系统的价值。
Cancer Cytopathol. 2021 Jan;129(1):75-82. doi: 10.1002/cncy.22345. Epub 2020 Aug 18.
9
Application of the International System for Reporting Serous Fluid Cytopathology to pericardial fluid: Root cause analysis of indeterminate diagnoses, cytohistological correlation, and assessment of malignancy risk.国际浆膜腔液细胞病理学报告系统在心包液中的应用:不明确诊断的根本原因分析、细胞组织学相关性及恶性风险评估。
Cancer Cytopathol. 2023 Jul;131(7):433-441. doi: 10.1002/cncy.22696. Epub 2023 Mar 27.
10
Application of the International System for Reporting Serous Fluid Cytopathology in routine reporting of pleural effusion and assessment of the risk of malignancy.国际浆膜腔液细胞病理学报告系统在胸腔积液常规报告中的应用及恶性肿瘤风险评估。
Diagn Cytopathol. 2021 Oct;49(10):1089-1098. doi: 10.1002/dc.24837. Epub 2021 Jul 21.

引用本文的文献

1
The Role of Immunohistochemistry in Reducing the "Atypia of Undetermined Significance (AUS)" Category in Serous Fluid Cytology.免疫组织化学在减少浆液性液体细胞学中“意义未明的非典型性(AUS)”类别方面的作用。
J Cytol. 2025 Jan-Mar;42(1):43-47. doi: 10.4103/joc.joc_212_23. Epub 2025 Feb 11.
2
An Artificial Intelligence-assisted Diagnostic System Improves Upper Urine Tract Cytology Diagnosis.人工智能辅助诊断系统提高上尿路细胞学诊断水平。
In Vivo. 2024 Nov-Dec;38(6):3016-3021. doi: 10.21873/invivo.13785.
3
Role of Ancillary Techniques in Reporting Serous Fluid Cytology - "Redefining Categories, Refining Diagnosis".
辅助技术在浆液性液体细胞学报告中的作用——“重新定义类别,优化诊断”
J Cytol. 2024 Apr-Jun;41(2):96-104. doi: 10.4103/joc.joc_114_23. Epub 2024 Apr 24.
4
A retrospective analysis of serous effusions based on the newly proposed international system for reporting serous fluid cytopathology: a report of 3633 cases in an oncological center.基于新提出的国际浆膜腔液细胞学报告系统的浆膜腔积液回顾性分析:肿瘤中心 3633 例病例报告。
Diagn Pathol. 2022 Jul 2;17(1):56. doi: 10.1186/s13000-022-01241-4.